Refine by
Mri Diagnostic Articles & Analysis
6 news found
CardioWise, Inc. has recently completed development of the first fully integrated version of its Multiparametric Strain Analysis Software (MPSA™), which is uniquely capable of analyzing the three-dimensional motion of the heart that is acquired from cardiac MRI images and then comparing the analysis at 15,300 points to the motion of a normal heart model. ...
This tool performs segmentation of the shoulder bones from shoulder MRI scan, which is usually performed in shoulder healthcare. The segmentation output undergoes super-resolution enhancement to overcome inherent MRI resolution limitations. ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today provided a general corporate update. 2021 Highlights Implanted first U.S. patient in the DREAM IDE pivotal study in December 2020; there are currently ...
This project, led by Oxford Brain Diagnostics and Dr Nakajima, will gather real world MRI patient data, and will use CDM analysis, based on changes at the cellular level, to assess dementia disease severity and potentially support differential diagnosis. ...
Clinical validation testing of the CardioWise analysis software on separate MRI scans acquired on the same patient on the same MRI, as well as scans acquired on the same patient but on different MRI systems. ...
” The MPS™ software currently under development by CardioWise is uniquely capable of analyzing the movement of the heart captured by cardiac MRI images. The parts of the heart with damage have abnormal movement patterns and the post-MRI analysis clearly shows where and to what degree the muscle has been damaged. Unlike many other ...